CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- Open-market buys, last 90 days
- $884,752
- in 1 filing
- Open-market sales, last 90 days
- $1,763,410
- in 5 filings, $1.8M under 10b5-1 plans
Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 5 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-09 | Lucchino David L. President and CEO | Sale | −13,514 | $32.93 | $445K | 323,800 |
| 2020-12-09 | Lucchino David L. President and CEO | Exercise or conversion · Stock Option | −13,514 | 23,838 | ||
| 2020-12-08 | Lucchino David L. President and CEO | Exercise or conversion | +8,848 | $0.61 | $5K | 332,648 |
| 2020-12-08 | Lucchino David L. President and CEO | Sale | −4,050 | $30.96 | $125K | 328,598 |
| 2020-12-08 | Lucchino David L. President and CEO | Sale | −4,798 | $31.52 | $151K | 323,800 |
| 2020-12-08 | Lucchino David L. President and CEO | Exercise or conversion · Stock Option | −8,848 | 37,352 | ||
| 2020-12-07 | Lucchino David L. President and CEO | Exercise or conversion | +4,666 | $0.61 | $3K | 328,466 |
| 2020-12-07 | Lucchino David L. President and CEO | Sale | −4,666 | $30.02 | $140K | 323,800 |
| 2020-12-07 | Lucchino David L. President and CEO | Exercise or conversion · Stock Option | −4,666 | 46,200 | ||
| 2020-12-02 | PFREUNDSCHUH PETER P. Chief Financial Officer | Grant or award · Stock Option | +230,000 | 230,000 | ||
| 2020-12-01 | Lucchino David L. President and CEO | Sale | −15,114 | $27.90 | $422K | 324,400 |
| 2020-12-01 | Lucchino David L. President and CEO | Sale | −600 | $28.65 | $17K | 323,800 |
| 2020-11-17 | LANGER ROBERT Director | Gift | −56,912 | 214,326 | ||
| 2020-11-09 | Loose Christopher R. Chief Scientific Officer | Sale | −8,000 | $24.00 | $192K | 71,782 |
| 2020-11-05 | Loose Christopher R. Chief Scientific Officer | Sale | −8,000 | $23.00 | $184K | 79,782 |
| 2020-11-02 | Lucchino David L. President and CEO | Sale | −12,965 | $20.68 | $268K | 342,263 |
| 2020-11-02 | Lucchino David L. President and CEO | Sale | −2,749 | $21.41 | $59K | 339,514 |
| 2020-10-13 | Loose Christopher R. Chief Scientific Officer | Sale | −8,000 | $22.00 | $176K | 87,782 |
| 2020-10-08 | Loose Christopher R. Chief Scientific Officer | Sale | −8,000 | $21.12 | $169K | 95,782 |
| 2020-10-07 | Loose Christopher R. Chief Scientific Officer | Sale | −8,000 | $20.00 | $160K | 103,782 |
Page 28 of 34 · 670 trades